BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1002 related articles for article (PubMed ID: 23040568)

  • 1. Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction.
    Akiyama E; Sugiyama S; Matsuzawa Y; Konishi M; Suzuki H; Nozaki T; Ohba K; Matsubara J; Maeda H; Horibata Y; Sakamoto K; Sugamura K; Yamamuro M; Sumida H; Kaikita K; Iwashita S; Matsui K; Kimura K; Umemura S; Ogawa H
    J Am Coll Cardiol; 2012 Oct; 60(18):1778-86. PubMed ID: 23040568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Significance of Peripheral Microvascular Endothelial Dysfunction in Heart Failure With Reduced Left Ventricular Ejection Fraction.
    Fujisue K; Sugiyama S; Matsuzawa Y; Akiyama E; Sugamura K; Matsubara J; Kurokawa H; Maeda H; Hirata Y; Kusaka H; Yamamoto E; Iwashita S; Sumida H; Sakamoto K; Tsujita K; Kaikita K; Hokimoto S; Matsui K; Ogawa H
    Circ J; 2015; 79(12):2623-31. PubMed ID: 26489455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction measured by peripheral arterial tonometry predicts prognosis in patients with heart failure with preserved ejection fraction.
    Matsue Y; Suzuki M; Nagahori W; Ohno M; Matsumura A; Hashimoto Y; Yoshida K; Yoshida M
    Int J Cardiol; 2013 Sep; 168(1):36-40. PubMed ID: 23021763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of tissue Doppler E/e' ratio in hypertension patients with preserved left ventricular ejection fraction.
    Zhou D; Huang Y; Fu M; Cai A; Tang S; Feng Y
    Clin Exp Hypertens; 2018; 40(6):554-559. PubMed ID: 29400582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of left ventricular diastolic dysfunction to heart failure regardless of ejection fraction.
    Brucks S; Little WC; Chao T; Kitzman DW; Wesley-Farrington D; Gandhi S; Shihabi ZK
    Am J Cardiol; 2005 Mar; 95(5):603-6. PubMed ID: 15721099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function.
    Valle R; Aspromonte N; Feola M; Milli M; Canali C; Giovinazzo P; Carbonieri E; Ceci V; Cerisano S; Barro S; Milani L
    J Card Fail; 2005 Sep; 11(7):498-503. PubMed ID: 16198244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction.
    Izumiya Y; Hanatani S; Kimura Y; Takashio S; Yamamoto E; Kusaka H; Tokitsu T; Rokutanda T; Araki S; Tsujita K; Tanaka T; Yamamuro M; Kojima S; Tayama S; Kaikita K; Hokimoto S; Ogawa H
    Can J Cardiol; 2014 Mar; 30(3):338-44. PubMed ID: 24484911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial function and cardiovascular events in chronic kidney disease.
    Hirata Y; Sugiyama S; Yamamoto E; Matsuzawa Y; Akiyama E; Kusaka H; Fujisue K; Kurokawa H; Matsubara J; Sugamura K; Maeda H; Iwashita S; Jinnouchi H; Matsui K; Ogawa H
    Int J Cardiol; 2014 May; 173(3):481-6. PubMed ID: 24703800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of cystatin C on admission in heart failure with preserved ejection fraction.
    Carrasco-Sánchez FJ; Galisteo-Almeda L; Páez-Rubio I; Martínez-Marcos FJ; Camacho-Vázquez C; Ruiz-Frutos C; Pujol-De La Llave E
    J Card Fail; 2011 Jan; 17(1):31-8. PubMed ID: 21187262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of indeterminable anaerobic threshold in heart failure.
    Agostoni P; Corrà U; Cattadori G; Veglia F; Battaia E; La Gioia R; Scardovi AB; Emdin M; Metra M; Sinagra G; Limongelli G; Raimondo R; Re F; Guazzi M; Belardinelli R; Parati G; Magrì D; Fiorentini C; Cicoira M; Salvioni E; Giovannardi M; Mezzani A; Scrutinio D; Di Lenarda A; Mantegazza V; Ricci R; Apostolo A; Iorio A; Paolillo S; Palermo P; Contini M; Vassanelli C; Passino C; Piepoli MF;
    Circ Heart Fail; 2013 Sep; 6(5):977-87. PubMed ID: 23881847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
    Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
    J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of usefulness of echocardiographic Doppler variables to left ventricular end-diastolic pressure in predicting future heart failure events.
    Liang HY; Cauduro SA; Pellikka PA; Bailey KR; Grossardt BR; Yang EH; Rihal C; Seward JB; Miller FA; Abraham TP
    Am J Cardiol; 2006 Mar; 97(6):866-71. PubMed ID: 16516591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular diastolic function, assessed by echocardiography and tissue Doppler imaging, is a strong predictor of cardiovascular events, superior to global left ventricular longitudinal strain, in patients with type 2 diabetes.
    Blomstrand P; Engvall M; Festin K; Lindström T; Länne T; Maret E; Nyström FH; Maret-Ouda J; Östgren CJ; Engvall J
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):1000-7. PubMed ID: 25750201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis in patients with heart failure and preserved left ventricular systolic function.
    Dias P; Rodrigues RA; Queirós MC; Monteiro E; Pimenta J; Friões F; Ferreira A; Bettencourt P
    Rev Port Cardiol; 2001 Dec; 20(12):1223-32. PubMed ID: 11865682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and prognosis of heart failure with normal left ventricular ejection fraction in elderly patients.
    Liu DP; Wang F; Zeng XZ; Zhang XC
    Chin Med J (Engl); 2012 Aug; 125(16):2853-7. PubMed ID: 22932079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure.
    Gavazzi A; Berzuini C; Campana C; Inserra C; Ponzetta M; Sebastiani R; Ghio S; Recusani F
    J Heart Lung Transplant; 1997 Jul; 16(7):774-85. PubMed ID: 9257260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic impact of heart failure with preserved versus reduced ejection fraction in patients with mild symptoms].
    Jung P; Huber T; Müller M; König A; Krötz F; Sohn HY
    Dtsch Med Wochenschr; 2012 Apr; 137(14):706-10. PubMed ID: 22454198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart failure with normal left ventricular ejection fraction: what is the evidence?
    Kindermann M; Reil JC; Pieske B; van Veldhuisen DJ; Böhm M
    Trends Cardiovasc Med; 2008 Nov; 18(8):280-92. PubMed ID: 19345315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Parissis JT; Nikolaou M; Birmpa D; Farmakis D; Paraskevaidis I; Bistola V; Katsoulas T; Filippatos G; Kremastinos DT
    Am J Cardiol; 2009 Jan; 103(1):73-5. PubMed ID: 19101233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.